What is the recommended way to monitor response to therapy after starting a diet or pharmacologic treatment in chronic enteropathy?

• A. Reassess clinical signs, track weight and stool quality, monitor appetite; recheck CBC/Chem and albumin and adjust therapy accordingly
• B. Only remeasure weight
• C. Only evaluate stool quality
• D. Only measure albumin

Answer: (A)

Monitoring response after starting diet or drug therapy in chronic enteropathy requires a holistic check: reassess how the animal is doing clinically, track objective signs like weight and stool quality, watch appetite, and recheck key laboratory values such as CBC, chemistry, and albumin to guide any therapy adjustments. This multi-dimensional approach is best because clinical improvement (how the animal feels and behaves) can occur before perfect lab normalization, while objective measures like weight and stool quality provide tangible evidence of mucosal health and function. CBC and chemistry reveal inflammation, organ function, and overall protein status, and albumin specifically helps detect protein-losing enteropathy or systemic effects. Relying on a single parameter risks missing ongoing disease activity or relapse—for example, stool quality might improve before weight stabilizes, or albumin may lag behind clinical improvement. Therefore, a combined, regular reassessment gives the most accurate picture of how well the treatment is working and when to adjust therapy.